407 related articles for article (PubMed ID: 16224818)
41. The effects of macrophage migratory inhibitory factor on acute-phase protein production in primary human hepatocytes.
Wheelhouse NM; Dowidar N; Dejong CH; Garden OJ; Powell JJ; Barber MD; Sangster K; Maingay JP; Ross JA
Int J Mol Med; 2006 Nov; 18(5):957-61. PubMed ID: 17016627
[TBL] [Abstract][Full Text] [Related]
42. How glucocorticoids control their own strength and the balance between pro- and anti-inflammatory mediators.
Van Molle W; Libert C
Eur J Immunol; 2005 Dec; 35(12):3396-9. PubMed ID: 16331703
[TBL] [Abstract][Full Text] [Related]
43. Macrophage-colony-stimulating factor-induced proliferation and lipopolysaccharide-dependent activation of macrophages requires Raf-1 phosphorylation to induce mitogen kinase phosphatase-1 expression.
Sánchez-Tilló E; Comalada M; Farrera C; Valledor AF; Lloberas J; Celada A
J Immunol; 2006 Jun; 176(11):6594-602. PubMed ID: 16709817
[TBL] [Abstract][Full Text] [Related]
44. Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages.
Ikeda Y; Murakami A; Ohigashi H
Biochem Pharmacol; 2005 Nov; 70(10):1497-505. PubMed ID: 16188240
[TBL] [Abstract][Full Text] [Related]
45. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses.
Salojin KV; Owusu IB; Millerchip KA; Potter M; Platt KA; Oravecz T
J Immunol; 2006 Feb; 176(3):1899-907. PubMed ID: 16424221
[TBL] [Abstract][Full Text] [Related]
46. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease.
Donnelly SC; Bucala R
Mol Med Today; 1997 Nov; 3(11):502-7. PubMed ID: 9430786
[TBL] [Abstract][Full Text] [Related]
47. Mitogen-activated protein kinase phosphatase-1 expression in macrophages is controlled by lymphocytes during macrophage activation.
Luo C; Yang X; Yao L; Jiang L; Liu W; Li X; Wang L
Int J Mol Med; 2012 Jan; 29(1):25-31. PubMed ID: 21956667
[TBL] [Abstract][Full Text] [Related]
48. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
[TBL] [Abstract][Full Text] [Related]
49. Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor.
Sasakawa Y; Naoe Y; Sogo N; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
Biochem Pharmacol; 2005 Feb; 69(4):603-16. PubMed ID: 15670579
[TBL] [Abstract][Full Text] [Related]
50. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
Santos LL; Morand EF
Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
[TBL] [Abstract][Full Text] [Related]
51. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
52. Obacunone causes sustained expression of MKP-1 thus inactivating p38 MAPK to suppress pro-inflammatory mediators through intracellular MIF.
Gao Y; Hou R; Liu F; Liu H; Fei Q; Han Y; Cai R; Peng C; Qi Y
J Cell Biochem; 2018 Jan; 119(1):837-849. PubMed ID: 28657665
[TBL] [Abstract][Full Text] [Related]
53. Light-inducible and clock-controlled expression of MAP kinase phosphatase 1 in mouse central pacemaker neurons.
Doi M; Cho S; Yujnovsky I; Hirayama J; Cermakian N; Cato AC; Sassone-Corsi P
J Biol Rhythms; 2007 Apr; 22(2):127-39. PubMed ID: 17440214
[TBL] [Abstract][Full Text] [Related]
54. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
Morand EF
Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113
[TBL] [Abstract][Full Text] [Related]
55. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK.
Liu C; Shi Y; Du Y; Ning X; Liu N; Huang D; Liang J; Xue Y; Fan D
Exp Cell Res; 2005 Oct; 309(2):410-8. PubMed ID: 16081065
[TBL] [Abstract][Full Text] [Related]
56. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
57. Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.
Calandra T; Froidevaux C; Martin C; Roger T
J Infect Dis; 2003 Jun; 187 Suppl 2():S385-90. PubMed ID: 12792855
[TBL] [Abstract][Full Text] [Related]
58. MAPK phosphatases--regulating the immune response.
Liu Y; Shepherd EG; Nelin LD
Nat Rev Immunol; 2007 Mar; 7(3):202-12. PubMed ID: 17318231
[TBL] [Abstract][Full Text] [Related]
59. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
[TBL] [Abstract][Full Text] [Related]
60. Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).
Kim S; Miska KB; Jenkins MC; Fetterer RH; Cox CM; Stuard LH; Dalloul RA
Dev Comp Immunol; 2010 Sep; 34(9):1021-32. PubMed ID: 20470818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
